<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03223233</url>
  </required_header>
  <id_info>
    <org_study_id>2016/12.2</org_study_id>
    <nct_id>NCT03223233</nct_id>
  </id_info>
  <brief_title>Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels</brief_title>
  <official_title>Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The serum procalcitonin levels are important during infections and sepsis. The investigators
      aimed to assess its predictive value in terms of post-cesarean wound infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The serum procalcitonin levels are important during infections and sepsis. Recent studies
      showed that serum procalcitonin levels are more sensitive than serum CRP levels.The
      investigators aimed to assess its predictive value in terms of post-cesarean wound infection.
      The serum procalcitonin levels are aimed to measure in participants who had cesarean section
      and developed surgical site infection. The investigators aimed to compare the serum
      procalcitonin levels between the patients who need secondary suture and the patients who did
      not need secondary suture.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Actual">October 8, 2017</completion_date>
  <primary_completion_date type="Actual">September 29, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>2 Weeks</target_duration>
  <primary_outcome>
    <measure>Serum procalcitonin levels in participants who developed wound infection after cesarean sections</measure>
    <time_frame>5 months</time_frame>
    <description>Serum procalcitonin levels will be measured in participants who will develop post-cesarean wound site infections. The serum procalcitonin levels will be compared in subgroups who need secondary suture and those who don't require suturing</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Wound Infection</condition>
  <condition>Cesarean Wound Disruption</condition>
  <arm_group>
    <arm_group_label>No secondary suture</arm_group_label>
    <description>The participants who developed post-cesarean surgical site infection and follow-up only antibiotic treatment for their wound care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary suture</arm_group_label>
    <description>The participants who developed post-cesarean surgical site infection and need a secondary suture for their wound care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>procalcitonin level</intervention_name>
    <description>serum procalcitonin level will be measured in both groups.</description>
    <arm_group_label>No secondary suture</arm_group_label>
    <arm_group_label>Secondary suture</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participants are post-cesarean patients who developed surgical site infections.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  who developed surgical site infection after their cesarean sections.

          -  18-40 years old

        Exclusion Criteria:

          -  history of chorioamnionitis and premature rupture of membranes

          -  urinary tract infections

          -  any infectious condition other than surgical site infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Patients who underwent cesarean section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alev Atis, MD,ObGyn</last_name>
    <role>Study Director</role>
    <affiliation>Kanuni Sultan Suleyman Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kanuni SSRTH</name>
      <address>
        <city>Istanbul</city>
        <zip>34303</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013 May;13(5):426-35. doi: 10.1016/S1473-3099(12)70323-7. Epub 2013 Feb 1. Review.</citation>
    <PMID>23375419</PMID>
  </reference>
  <reference>
    <citation>Takakura Y, Hinoi T, Egi H, Shimomura M, Adachi T, Saito Y, Tanimine N, Miguchi M, Ohdan H. Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery. Langenbecks Arch Surg. 2013 Aug;398(6):833-9. doi: 10.1007/s00423-013-1095-0. Epub 2013 Jun 20.</citation>
    <PMID>23784676</PMID>
  </reference>
  <results_reference>
    <citation>Erenel H, Yilmaz N, Oncul M, Acikgoz AS, Karatas S, Ayhan I, Aslan B, Tuten A. Usefulness of Serum Procalcitonin Levels in Predicting Tubo-Ovarian Abscess in Patients with Acute Pelvic Inflammatory Disease. Gynecol Obstet Invest. 2017;82(3):262-266. doi: 10.1159/000449161. Epub 2016 Sep 3.</citation>
    <PMID>27592364</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2017</study_first_posted>
  <last_update_submitted>October 22, 2017</last_update_submitted>
  <last_update_submitted_qc>October 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Berna Aslan Cetin</investigator_full_name>
    <investigator_title>MD,ObGYN</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

